Mr. Kilcoyne brings more than 33 years of experience in the medical device market to ReVision Optics. He understands the needs of both patients and physicians combined with an ability to lead companies from the development to commercialization stage as well as through mergers and Initial Public Offerings (IPO). Prior to joining ReVision Optics, Mr. Kilcoyne has lead three organizations, two of which were acquired, creating shareholder value in excess of $500M. In 2005, he took Micrus Endovascular public (NASDAQ) then successfully led the company until its acquisition by Johnson and Johnson in 2010. Mr. Kilcoyne currently serves on the AdvaMed Board of Directors and AdvaMed/Accel Board of Directors and is the current Chair of the AdvaMed Ophthalmic Sector.